The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | Improving TTD for CBCL
Amra Osmancevic
• 15 Oct 2021
Amra Osmancevic, MD, PhD, University of Gothenburg, Gothenburg, Sweden, discusses ways in which the time to diagnosis (TTD) of cutaneous B-cell lymphomas can be diagnosed early, commenting on key challenges and the importance of public awareness of symptoms. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
